We are live on ! Find out more
NIM

NEOS Investment Management Portfolio holdings

AUM $27.1B
1-Year Est. Return 57.21%
This Fund
S&P 500
This Quarter Est. Return
+6.42%
1 Year Est. Return
+57.21%
3 Year Est. Return
+163.05%
5 Year Est. Return
10 Year Est. Return
AUM
$2.43B
AUM Growth
+$814M
Cap. Flow
+$708M
Cap. Flow %
29.14%
Top 10 Hldgs %
36.44%
Holding
590
New
24
Increased
504
Reduced
11
Closed
21

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$45.8M
2
AAPL icon
Apple
AAPL
+$39.2M
3
NVDA icon
NVIDIA
NVDA
+$34.5M
4
AMZN icon
Amazon
AMZN
+$23.5M
5
META icon
Meta Platforms (Facebook)
META
+$18.4M

Sector Composition

Rank Sector Weight
1 Technology 36.52%
2 Healthcare 13.99%
3 Communication Services 10.54%
4 Consumer Discretionary 9.76%
5 Financials 7.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTLT
551
DELISTED
CATALENT, INC.
CTLT
$226K 0.01%
+4,025
New +$225K
CGON icon
552
CG Oncology
CGON
$6.5B
$222K 0.01%
+7,039
New +$244K
ZBRA icon
553
Zebra Technologies
ZBRA
$16.4B
$220K 0.01%
712
HAS icon
554
Hasbro
HAS
$12.7B
$220K 0.01%
+3,756
New +$223K
CNI icon
555
Canadian National Railway
CNI
$72.4B
$219K 0.01%
1,855
-720
-28% -$90.2K
CP icon
556
Canadian Pacific Kansas City
CP
$77.4B
$219K 0.01%
2,777
-1,073
-28% -$87.3K
BEN icon
557
Franklin Templeton
BEN
$16.9B
$217K 0.01%
+9,728
New +$234K
PRTA icon
558
Prothena Corp
PRTA
$424M
$217K 0.01%
+10,511
New +$227K
FDS icon
559
Factset
FDS
$9.78B
$216K 0.01%
530
AVY icon
560
Avery Dennison
AVY
$13.2B
$213K 0.01%
972
TAP icon
561
Molson Coors Class B
TAP
$7.26B
$205K 0.01%
4,025
+996
+33% +$57.6K
CPRX
562
DELISTED
Catalyst Pharmaceutical
CPRX
$176K 0.01%
11,352
ACAD icon
563
Acadia Pharmaceuticals
ACAD
$4.68B
$172K 0.01%
+10,596
New +$171K
PARA
564
DELISTED
Paramount Global Class B
PARA
$171K 0.01%
16,453
+4,980
+43% +$58.3K
FATE icon
565
Fate Therapeutics
FATE
$285M
$156K 0.01%
47,468
+27,645
+139% +$121K
VYGR icon
566
Voyager Therapeutics
VYGR
$187M
$118K ﹤0.01%
14,960
LCID icon
567
Lucid Motors
LCID
$1.6B
$88.4K ﹤0.01%
3,387
+1,452
+75% +$38.8K
ALEC icon
568
Alector
ALEC
$223M
$65.1K ﹤0.01%
14,344
TALK
569
DELISTED
Talkspace
TALK
$60.6K ﹤0.01%
26,337
-19,115
-42% -$55K
ACHC icon
570
Acadia Healthcare
ACHC
$2.63B
-2,596
Closed -$206K
EPAM icon
571
EPAM Systems
EPAM
$6.11B
-805
Closed -$222K
IEX icon
572
IDEX
IEX
$16.4B
-972
Closed -$237K
JAZZ icon
573
Jazz Pharmaceuticals
JAZZ
$15.8B
-1,672
Closed -$201K
LECO icon
574
Lincoln Electric
LECO
$14B
-2,332
Closed -$596K
LH icon
575
Labcorp
LH
$26.2B
-973
Closed -$213K

Similar funds

NEOS Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, NEOS Investment Management held 590 positions worth $2.43B, up 50% from $1.61B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

NEOS Investment Management deployed $708M of net new capital in Q2 2024, opening 24 new positions and adding to 504 existing holdings. Its largest new stake was Primoris Services: 53,757 shares worth $2.68M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Healthcare and Communication Services.

On the sell side, the largest reduction was Madrigal Pharmaceuticals, an estimated $234K trimmed.

  • NEOS Investment Management's largest Q2 2024 buy was Primoris Services: 53,757 shares worth $2.68M.
  • NEOS Investment Management added most to Microsoft in Q2 2024, an estimated $45.8M increase.
  • NEOS Investment Management's biggest Q2 2024 reduction was Madrigal Pharmaceuticals, cutting an estimated $234K.
  • NEOS Investment Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $1.85M.
  • NEOS Investment Management's ten largest holdings make up 36% of its $2.43B portfolio in Q2 2024.
  • NEOS Investment Management opened 24 new positions and closed 21 in Q2 2024.
  • NEOS Investment Management's portfolio value rose 50% quarter-over-quarter to $2.43B.

Based on NEOS Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.